162 related articles for article (PubMed ID: 33923502)
1. Urinary Biomarkers for Early Diagnosis of Lung Cancer.
Gasparri R; Sedda G; Caminiti V; Maisonneuve P; Prisciandaro E; Spaggiari L
J Clin Med; 2021 Apr; 10(8):. PubMed ID: 33923502
[TBL] [Abstract][Full Text] [Related]
2. Urinary biomarkers in prostate cancer detection and monitoring progression.
Wu D; Ni J; Beretov J; Cozzi P; Willcox M; Wasinger V; Walsh B; Graham P; Li Y
Crit Rev Oncol Hematol; 2017 Oct; 118():15-26. PubMed ID: 28917266
[TBL] [Abstract][Full Text] [Related]
3. Urinary Biomarkers and Their Potential for the Non-Invasive Detection of Endometrial Cancer.
Njoku K; Chiasserini D; Jones ER; Barr CE; O'Flynn H; Whetton AD; Crosbie EJ
Front Oncol; 2020; 10():559016. PubMed ID: 33224875
[TBL] [Abstract][Full Text] [Related]
4. Urinary protein biomarkers in the early detection of lung cancer.
Nolen BM; Lomakin A; Marrangoni A; Velikokhatnaya L; Prosser D; Lokshin AE
Cancer Prev Res (Phila); 2015 Feb; 8(2):111-9. PubMed ID: 25416410
[TBL] [Abstract][Full Text] [Related]
5. Urine protein biomarkers for the detection, surveillance, and treatment response prediction of bladder cancer.
Chakraborty A; Dasari S; Long W; Mohan C
Am J Cancer Res; 2019; 9(6):1104-1117. PubMed ID: 31285945
[TBL] [Abstract][Full Text] [Related]
6. Urinary Exosomal MicroRNAs as Potential Non-invasive Biomarkers in Breast Cancer Detection.
Hirschfeld M; Rücker G; Weiß D; Berner K; Ritter A; Jäger M; Erbes T
Mol Diagn Ther; 2020 Apr; 24(2):215-232. PubMed ID: 32112368
[TBL] [Abstract][Full Text] [Related]
7. Metabolomic-based biomarker discovery for non-invasive lung cancer screening: A case study.
O'Shea K; Cameron SJ; Lewis KE; Lu C; Mur LA
Biochim Biophys Acta; 2016 Nov; 1860(11 Pt B):2682-7. PubMed ID: 27423423
[TBL] [Abstract][Full Text] [Related]
8. Early lung cancer diagnostic biomarker discovery by machine learning methods.
Xie Y; Meng WY; Li RZ; Wang YW; Qian X; Chan C; Yu ZF; Fan XX; Pan HD; Xie C; Wu QB; Yan PY; Liu L; Tang YJ; Yao XJ; Wang MF; Leung EL
Transl Oncol; 2021 Jan; 14(1):100907. PubMed ID: 33217646
[TBL] [Abstract][Full Text] [Related]
9. The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.
Guldbrandt LM
Dan Med J; 2015 Mar; 62(3):. PubMed ID: 25748876
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Emerging Utility of Urinary Cell-free Nucleic Acid Biomarkers for Prostate, Bladder, and Renal Cancers.
Lin SY; Linehan JA; Wilson TG; Hoon DSB
Eur Urol Focus; 2017 Apr; 3(2-3):265-272. PubMed ID: 28753876
[TBL] [Abstract][Full Text] [Related]
12. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
13. Approaches to the discovery of non-invasive urinary biomarkers of prostate cancer.
Jedinak A; Loughlin KR; Moses MA
Oncotarget; 2018 Aug; 9(65):32534-32550. PubMed ID: 30197761
[TBL] [Abstract][Full Text] [Related]
14. Developing urinary metabolomic signatures as early bladder cancer diagnostic markers.
Shen C; Sun Z; Chen D; Su X; Jiang J; Li G; Lin B; Yan J
OMICS; 2015 Jan; 19(1):1-11. PubMed ID: 25562196
[TBL] [Abstract][Full Text] [Related]
15. NMR-based metabolomic techniques identify potential urinary biomarkers for early colorectal cancer detection.
Wang Z; Lin Y; Liang J; Huang Y; Ma C; Liu X; Yang J
Oncotarget; 2017 Dec; 8(62):105819-105831. PubMed ID: 29285295
[TBL] [Abstract][Full Text] [Related]
16. Bladder cancer biomarker discovery using global metabolomic profiling of urine.
Wittmann BM; Stirdivant SM; Mitchell MW; Wulff JE; McDunn JE; Li Z; Dennis-Barrie A; Neri BP; Milburn MV; Lotan Y; Wolfert RL
PLoS One; 2014; 9(12):e115870. PubMed ID: 25541698
[TBL] [Abstract][Full Text] [Related]
17. The role of renal biomarkers to predict the need of surgery in congenital urinary tract obstruction in infants.
Kostic D; Beozzo GPNS; do Couto SB; Kato AHT; Lima L; Palmeira P; Krebs VLJ; Bunduki V; Francisco RPV; Zugaib M; Dénes FT; de Carvalho WB; Koch VHK
J Pediatr Urol; 2019 May; 15(3):242.e1-242.e9. PubMed ID: 30979613
[TBL] [Abstract][Full Text] [Related]
18. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
19. Emerging biomarkers for the diagnosis and monitoring of urothelial carcinoma.
Miyake M; Owari T; Hori S; Nakai Y; Fujimoto K
Res Rep Urol; 2018; 10():251-261. PubMed ID: 30588457
[TBL] [Abstract][Full Text] [Related]
20. Discovery and development of DNA methylation-based biomarkers for lung cancer.
Walter K; Holcomb T; Januario T; Yauch RL; Du P; Bourgon R; Seshagiri S; Amler LC; Hampton GM; S Shames D
Epigenomics; 2014 Feb; 6(1):59-72. PubMed ID: 24579947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]